BrainStorm Therapeutics won the Servier Discovery Award
Selected for the California Life Sciences FAST California program as the Servier Discovery Award winner.
News and publications from the BrainStorm Therapeutics ecosystem: awards, press features, talks, and the organoid science we follow.
Selected for the California Life Sciences FAST California program as the Servier Discovery Award winner.
Co-founder Dr. Maya Gosztyla took home the People’s Choice Award at The AI Conference 2025.
Robert Fremeau pitched BrainStorm’s AI-powered precision medicine platform at a Plug and Play pitch event.
BrainStorm Therapeutics placed in the top three at the Bits in Bio TechBio Startup Showcase in San Diego.
Our article on AI models and brain organoid data appears in California Life Sciences’ “AI in Action” issue.
The National Science Foundation highlighted our AI-powered human organoid technology.
Cutting-edge technologies from San Diego and Southern California academic research organizations, at Alexandria Tech Center.
Maya Gosztyla compares her organization strategies as a biotech co-founder with those from graduate school.
How BrainStorm pairs AI-powered computational drug discovery with patient-derived brain organoids.
November 3, 2023, at the Sanford Consortium for Regenerative Medicine, La Jolla, CA.
October 24–26, 2023, Boston, MA.
“The use of organoids in preclinical research has reached a tipping point.” From BioWorld.
Roche has launched a new research group it’s naming the Institute of Human Biology. From Endpoints News.
Over the past decade scientists have been using stem cells to grow so-called “mini brains”, dubbed organoids. A WSJ podcast.
A computer model helps researchers understand the connections between thousands of genes, and how they go awry in disease.
Imagine a futuristic society capable of curing devastating neurological disorders by recreating patients’ brains in a dish. From Forbes.
Talk to us about our precision neuroscience platform, our Parkinson’s disease program, or working with the BrainStorm team.